Cargando…

1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard?

Detalles Bibliográficos
Autores principales:	Levy, Antonin, Rivera, Sofia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195114/ https://www.ncbi.nlm.nih.gov/pubmed/32580882 http://dx.doi.org/10.1016/S0140-6736(20)30978-8

Ejemplares similares

Comment on Ivanov et al. Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 Pandemic. Medicina 2022, 58, 745
por: Ferini, Gianluca
Publicado: (2022)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis, Theodora A, et al.
Publicado: (2015)

Similar Outcomes of Standard Radiotherapy and Hypofractionated Radiotherapy Following Breast-Conserving Surgery
por: Hou, Hai-Ling, et al.
Publicado: (2015)

Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
por: Krug, David, et al.
Publicado: (2021)

Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery
por: Kim, Kyung Su, et al.
Publicado: (2016)

Impact of hypofractionation and tangential beam IMRT on the acute skin reaction in adjuvant breast cancer radiotherapy
por: Rudat, Volker, et al.
Publicado: (2016)

Extreme weekly hypofractionation in breast cancer in elderly
por: Blanco Parajón, Sonia, et al.
Publicado: (2020)

Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients
por: Sanz, Javier, et al.
Publicado: (2018)

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
por: Chatterjee, Sanjoy, et al.
Publicado: (2020)

Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors
por: Ciammella, Patrizia, et al.
Publicado: (2014)

Combined-modality hypofractionated radiotherapy for elderly patients with glioblastoma: setting a new standard
por: Vellayappan, Balamurugan A, et al.
Publicado: (2017)

Fatigue following radiotherapy of low-risk early breast cancer – a randomized controlled trial of intraoperative electron radiotherapy versus standard hypofractionated whole-breast radiotherapy: the COSMOPOLITAN trial (NCT03838419)
por: Forster, Tobias, et al.
Publicado: (2020)

Hypofractionation: The standard for external beam breast irradiation
por: Brunt, Adrian Murray, et al.
Publicado: (2023)

Incidental Axillary Dose of Tomotherapy in Hypofractionated Whole Breast Radiotherapy for Early Breast Cancer: A Dosimetrical Analysis
por: Yeo, Seung-Gu, et al.
Publicado: (2023)

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
por: Montero, Angel, et al.
Publicado: (2023)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial
por: Krug, David, et al.
Publicado: (2020)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
por: Schmitt, Martin, et al.
Publicado: (2022)

Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma
por: Valle, Luca F., et al.
Publicado: (2021)

Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes
por: Gadea, J., et al.
Publicado: (2021)

Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique
por: Zerella, Maria Alessia, et al.
Publicado: (2022)

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
por: Lazzari, Grazia, et al.
Publicado: (2017)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

New survival standards for advanced melanoma
por: Spain, Lavinia, et al.
Publicado: (2020)

Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
por: Park, Jongmoo, et al.
Publicado: (2018)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?
por: Pondé, Noam, et al.
Publicado: (2019)

Hypofractionated Hybrid Radiotherapy Techniques for Synchronous Bilateral Breast Cancer
por: Balaji, Karunakaran, et al.
Publicado: (2021)

Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy
por: Vieira, Larissa Aparecida Corrêa, et al.
Publicado: (2022)

Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies
por: Gill, Sharlene
Publicado: (2014)

A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors
por: Deutsch, Eric, et al.
Publicado: (2016)

Adjuvant chemotherapy for node negative, high Recurrence Score(TM) breast cancer: in defense of de-escalation
por: Lake, Diana, et al.
Publicado: (2019)

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost
por: van Schie, Marcel A., et al.
Publicado: (2019)

Three-week hypofractionated radiotherapy in early glottic cancer—a single institution retrospective study
por: Sudha, Arun Sankar, et al.
Publicado: (2022)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: Results of a single, institutional, retrospective study
por: Rudat, Volker, et al.
Publicado: (2017)

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose
por: Hong, ZhengShan, et al.
Publicado: (2023)

Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
por: Tovanabutra, Chokaew, et al.
Publicado: (2020)

Benefits of Adopting Hypofractionated Radiotherapy as a Standard of Care in Low-and Middle-Income Countries
por: Kraus, Ryan D., et al.
Publicado: (2022)

Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
por: Chen, Kunzhi, et al.
Publicado: (2023)

Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment
por: Vaidya, Jayant S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_83cdaid0ijbkib7jj1joa0gum9